Health
Waisman Biomanufacturing partners with Heat Biologics to manufacture COVID-19 vaccine – Mirage News
Waisman Biomanufacturing staff operate a centrifuge that allows for cell separation. The UW-Madison biopharmaceutical contract manufacturer is partnering…
Waisman Biomanufacturing staff operate a centrifuge that allows for cell separation. The UW-Madison biopharmaceutical contract manufacturer is partnering with Heat Biologics to produce a COVID-19 vaccine for phase 1 and phase 2 clinical trials. Todd Brown, Media Solutions, UW School of Medicine and Public Health
Waisman Biomanufacturing at the University of Wisconsin-Madison is partnering with Heat Biologics to produce a COVID-19 vaccine for phase 1 and phase 2 clinical trials. Phase 1 trials c…
-
Noosa News23 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General24 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General16 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
Noosa News13 hours agoAlternative pathways to university explained
